secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001437749-25-038047
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech regains Nasdaq bid price compliance after stock closes at $1.00+ for 10 days
--------------------------------------------------------------------------------

- Nasdaq confirmed compliance with Listing Rule 5550(a)(2) effective Dec 15, 2025.
- Cure based on closing bid price at or above $1.00 for 10 consecutive days ending Dec 12.
- Previous deficiency notice from June 27, 2025 is now closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925038047/0001437749-25-038047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925038047/mbrx20251215_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-038047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer